Victory Capital Management
MCRB icon

Victory Capital Management’s Seres Therapeutics MCRB Stock Holding History

Victory Capital Management’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-767
Closed -$10.7K – 2524
2025
Q1 		$10.7K Sell
767
-5
-0.6% -$78 ﹤0.01% 2451
2024
Q4 		$12.8K Buy
772
+7
+0.9% +$114 ﹤0.01% 2465
2024
Q3 		$14.5K Sell
765
-9
-1% -$183 ﹤0.01% 2461
2024
Q2 		$11.2K Buy
774
+23
+3% +$384 ﹤0.01% 2462
2024
Q1 		$11.6K Buy
751
+94
+14% +$2.03K ﹤0.01% 2463
2023
Q4 		$18.4K Buy
657
+129
+24% +$3.39K ﹤0.01% 2511
2023
Q3 		$25.1K Buy
528
+16
+3% +$1.22K ﹤0.01% 2435
2023
Q2 		$49K Sell
512
-11
-2% -$1.2K ﹤0.01% 2388
2023
Q1 		$59.4K Sell
523
-5
-0.9% -$541 ﹤0.01% 2426
2022
Q4 		$59.1K Hold
528
– – ﹤0.01% 2430
2022
Q3 		$68K Buy
+528
New +$54.1K ﹤0.01% 2527
2021
Q3 		– Sell
-790
Closed -$377K – 2816
2021
Q2 		$377K Sell
790
-347
-31% -$146K ﹤0.01% 2333
2021
Q1 		$468K Sell
1,137
-1,938
-63% -$892K ﹤0.01% 2235
2020
Q4 		$1.51M Buy
3,075
+845
+38% +$495K ﹤0.01% 1611
2020
Q3 		$1.26M Buy
+2,230
New +$742K ﹤0.01% 1606
2020
Q2 		– Sell
-492
Closed -$36K – 2945
2020
Q1 		$36K Buy
+492
New +$33K ﹤0.01% 2890
2019
Q4 		– Sell
-342
Closed -$27K – 2998
2019
Q3 		$27K Buy
+342
New +$22.6K ﹤0.01% 2942

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Victory Capital Management's MCRB Position: Q2 2025 in Review

Victory Capital Management sold out of Seres Therapeutics (MCRB) in Q2 2025, closing a stake of 767 shares — an estimated $10.7K sold.

Victory Capital Management first reported a position in MCRB in Q3 2019 and held it in 17 quarters. The position peaked at $1.51M in Q4 2020. 33 funds tracked by Wall St. Rank hold MCRB as of Q2 2025.

  • Victory Capital Management reported no remaining Seres Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Victory Capital Management sold 767 Seres Therapeutics shares in Q2 2025, an estimated $10.7K.
  • Victory Capital Management first reported a position in Seres Therapeutics in Q3 2019 and held it in 17 quarters.
  • Victory Capital Management's Seres Therapeutics position peaked at $1.51M in Q4 2020.
  • 33 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2025.

Based on Victory Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.